Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area

Pain

Volumn 109, Issue 3, 2004, Pages 367-378

  Bartsch, T ^a   Levy, M J ^a   Knight, Y E ^a   Goadsby, P J ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cluster headache; Endocrine; Headache; Hypocretin; Migraine; Nociception; Orexin; PH, posterior hypothalamic area; Posterior hypothalamus; Rat; TNC, caudal trigeminal nucleus

Indexed keywords

ANALGESIC AGENT; OREXIN A; OREXIN B;

AFFERENT NERVE GROUP 1; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL ACTIVITY; CONTROLLED STUDY; DURA MATER; ELECTROSTIMULATION; FACE; MALE; MICROINJECTION; NERVE FIBER C; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; POSTERIOR HYPOTHALAMUS; PRIORITY JOURNAL; RAT; THERMAL STIMULATION; TRIGEMINAL NUCLEUS;

ACTION POTENTIALS; ANIMALS; CARRIER PROTEINS; DURA MATER; GABA ANTAGONISTS; HEADACHE; HYPOTHALAMUS, POSTERIOR; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEURAL INHIBITION; NEURAL PATHWAYS; NEURONS; NEUROPEPTIDES; NOCICEPTORS; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; TRIGEMINAL CAUDAL NUCLEUS; TRIGEMINAL NERVE;

EID: 2442558400     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2004.02.005     Document Type: Article

References (65)

1. Abrahamson E.E., Leak R.K., Moore R.Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. NeuroReport. 12:2001;435-440
2. Bartsch T., Levy M.J., Knight Y.E., Goadsby P.J. Differential modulation of nociceptive dural input to [hypocretin] Orexin A and B receptor activation in the posterior hypothalamus. Cephalalgia. 23:2003;645
3. Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray. Prog Neurobiol. 46:1995;575-605
4. Bingham S., Davey P.T., Babbs A.J., Irving E.A., Sammons M.J., Wyles M., Jeffrey P., Cutler L., Riba I., Johns A., Porter R.A., Upton N., Hunter A.J., Parsons A.A. Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 92:2001;81-90
5. Blau J.N. Migraine prodromes separated from the aura; complete migraine. Br Med J. 21:1980;658-660
6. Buijs R.M., van Eden C.G. The integration of stress by the hypothalamus, amygdala and prefrontal cortex: balance between the autonomic nervous system and the neuroendocrine system. Prog Brain Res. 126:2000;117-132
7. Bussone G., Leone M., Zappacosta B.M., Maltempo C., Parnti A.E. A unifying concept of neuroendocrine dysfunctions in cluster headache. Ninth Migraine Trust International Symposium, London. 1992
8. Cluderay J.E., Harrison D.C., Hervieu G.J. Protein distribution of the orexin-2 receptor in the rat central nervous system. Reg Peptides. 104:2002;131-144
9. Cutler D.J., Morris R., Sheridhar V., Wattam T.A., Holmes S., Patel S., Arch J.R., Wilson S., Buckingham R.E., Evans M.L., Leslie R.A., Williams G. Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord. Peptides. 20:1999;1455-1470
10. Dalkvist J., Ekbom K., Waldenlind E. Headache and mood: a time-series analysis of self-ratings. Cephalalgia. 4:1984;45-52
11. Date Y., Ueta Y., Yamashita H., Yamaguchi H., Matsukura S., Kangawa K., Sakurai T., Yanagisawa M., Nakazato M. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA. 96:1999;748-753
12. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S. 2nd, Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 95:1998;322-327
13. DiMicco J.A., Abshire V.M., Hankins K.D., Sample R.H., Wible J.H. Jr. Microinjection of GABA antagonists into posterior hypothalamus elevates heart rate in anesthetized rats. Neuropharmacology. 25:1986;1063-1066
14. Drummond P.D., Lance J.W. Neurovascular disturbances in headache patients. Clin Exp Neurol. 20:1984;93-99
15. Edwards C.M., Abusnana S., Sunter D., Murphy K.G., Ghatei M.A., Bloom S.R. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol. 160:1999;R7-R12
16. Gao X.B., van den Pol A.N. Melanin concentrating hormone depresses synaptic activity of glutamate and GABA neurons from rat lateral hypothalamus. J Physiol. 533:2001;237-252
17. Giffin N.J., Ruggiero L., Lipton R.B., Silberstein S., Tvedskov J.F., Olesen J., Altman J., Goadsby P.J., Macrae A. Premonitory symptoms in migraine: an electronic diary study. Neurology. 60:2003;935-940
18. Goadsby P.J. The pathophysiology of headache. Silberstein S.D., Lipton R.B., Solomon S. Wolff's headache and other head pain. 2001;57-72 Oxford University Press, Oxford
19. Goadsby P.J. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol. 1:2002;37-43
20. Goder R., Fritzer G., Kapsokalyvas A., Kropp P., Niederberger U., Strenge H., Gerber W.D., Aldenhoff J.B. Polysomnographic findings in nights preceding a migraine attack. Cephalalgia. 21:2001;31-37
21. Grudt T.J., van den Pol A.N., Perl E.R. Hypocretin-2 (orexin-B) modulation of superficial dorsal horn activity in rat. J Physiol. 538:2002;517-525
22. Hagan J.J., Leslie R.A., Patel S., Evans M.L., Wattam T.A., Holmes S., Benham C.D., Taylor S.G., Routledge C., Hemmati P., Munton R.P., Ashmeade T.E., Shah A.S., Hatcher J.P., Hatcher P.D., Jones D.N., Smith M.I., Piper D.C., Hunter A.J., Porter R.A., Upton N. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 96:1999;10911-10916
23. Hervieu G.J., Cluderay J.E., Harrison D.C., Roberts J.C., Leslie R.A. Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord. Neuroscience. 103:2001;777-797
24. Holstege G. Some anatomical observations on the projections from the hypothalamus to brainstem and spinal cord: an HRP and autoradiographic tracing study in the cat. J Comp Neurol. 260:1987;98-126
25. Horvath T.L., Peyron C., Diano S., Ivanov A., Aston-Jones G., Kilduff T.S., van Den Pol A.N. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol. 415:1999;145-159
26. Hoskin K.L., Bulmer D.C.E., Lasalandra M., Jonkman A., Goadsby P.J. Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat. 197:2001;29-35
27. Isler H.-R. Frequency and time course of premonitory phenomena. Amery W.K., Wauquier A. The prelude to the migraine attack. 1986;Balliere Tindall, London
28. Keay K.A., Bandler R. Vascular head pain selectively activates ventrolateral periaqueductal gray in the cat. Neurosci Lett. 245:1998;58-60
29. Knight Y.E., Goadsby P.J. The periaqueductal gray matter modulates trigeminovascular input: a role in migraine? Neuroscience. 106:2001;793-800
30. Knight Y.E., Bartsch T., Kaube H., Goadsby P.J. P/Q-type calcium channel blockade in the PAG facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci. 22:2002;1-6
31. Knight Y.E., Bartsch T., Goadsby P.J. Trigeminal antinociception induced by bicuculline in the periaqueductal grey (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neurosci Lett. 336:2003;113-116
32. Leone M., Franzini A., D'Amico D., Grazzi L., Rigamonti A., Usai S., Broggi G., Bussone G. Stereotactic electrode implant in inferior posterior hypothalamic gray matter to relieve intractable chronic cluster headache: the first reported case. Neurology. 56:2001;A218
33. Leone M., Franzini A., Bussone G. Stereotatic stimulation of the posterior hypothalamic gray matter in a patient with intractable cluster headache. N Engl J Med. 345:2001;1428-1429
34. Manning B.H., Franklin K.B. Morphine analgesia in the formalin test: reversal by microinjection of quaternary naloxone into the posterior hypothalamic area or periaqueductal gray. Behav Brain Res. 92:1998;97-102
35. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 435:2001;6-25
36. May A., Bahra A., Buchel C., Frackowiak R.S.J., Goadsby P.J. Hypothalamic activation in cluster headache attacks. Lancet. 352:1998;275-278
37. May A., Ashburner J., Buchel C., McGonigle D.J., Friston K.J., Frackowiak R.S.J., Goadsby P.J. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 5:1999;836-838
38. Mayanagi Y., Sano K., Suzuki I., Kanazawa I., Aoyagi I., Miyachi Y. Stimulation and coagulation of the posteromedial hypothalamus for intractable pain, with reference to beta-endorphins. Appl Neurophysiol. 45:1982;136-142
39. Millan M.J., Przewlocki R., Millan M.H., Herz A. Evidence for a role of the ventro-medial posterior hypothalamus in nociceptive processes in the rat. Pharmacol Biochem Behav. 18:1983;901-907
40. Molander C., Grant G. Spinal cord cytoarchitecture. Paxinos G. The nervous system. 1995;Academic Press, San Diego, CA
41. Moore R.Y. Circadian rhythms: basic neurobiology and clinical applications. Annu Rev Med. 48:1997;253-266
42. Nambu T., Sakurai T., Mizukami K., Hosoya Y., Yanagisawa M., Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 827:1999;243-260
43. Olesen J., Goadsby P.J. Cluster headache and related conditions. vol. 9:1999;Oxford University Press, Oxford. 309 pp
44. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 1998;Academic Press, London
45. Peres M.F., Sanchez del Rio M., Seabra S., Tufik M.L., Abucham S., Cipolla-Neto J., Silberstein S.D., Zukerman E. Hypothalamic involvement in chronic migraine. J Neurol Neurosurg Psychiatry. 71:2001;747-751
46. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 18:1998;9996-10015
47. Pringsheim T. Cluster headache: evidence for a disorder of circadian rhythm and hypothalamic function. Can J Neurol Sci. 29:2002;33-40
48. Raimondi E. Cluster headache. Premonitory symptoms. Headache. 39:1999;565-566
49. Reynolds D.V. Surgery in the rat during electrical analgesia induced by focal brain stimulation. Science. 164:1969;444-445
50. Rhodes D.L., Liebeskind J.C. Analgesia from rostral brain stem stimulation in the rat. Brain Res. 143:1978;521-532
51. Sakurai T. Roles of orexins in regulation of feeding and wakefulness. NeuroReport. 13:2002;987-995
52. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins, and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;696-697
53. Smart D. Orexins: a new family of neuropeptides. Br J Anaesth. 83:1999;695-697
54. Smart D., Jerman J. The physiology and pharmacology of the orexins. Pharmacol Ther. 94:2002;51
55. Sutcliffe J.G., de Lecea L. The hypocretins: setting the arousal threshold. Nat Rev Neurosci. 3:2002;339-349
56. Trivedi P., Yu H., MacNeil D.J., Van der Ploeg L.H., Guan X.M. Distribution of orexin receptor mRNA in the rat brain. FEBS Lett. 438:1998;71-75
57. van den Pol A.N. Hypothalamic hypocretin (orexin): robust innervation of the spinal cord. J Neurosci. 19:1999;3171-3182
58. van den Pol A.N. Narcolepsy: a neurodegenerative disease of the hypocretin system? Neuron. 27:2000;415-418
59. van den Pol A.N., Gao X.B., Obrietan K., Kilduff T.S., Belousov A.B. Presynaptic and postsynaptic actions and modulation of neuroendocrine neurons by a new hypothalamic peptide, hypocretin/orexin. J Neurosci. 18:1998;7962-7971
60. Veazey R.B., Amaral D.G., Cowan W.M. The morphology and connections of the posterior hypothalamus in the cynomolgus monkey (macaca fascicularis). II. Efferent connections. J Comp Neurol. 207:1982;135-156
61. Waldrop T.G., Bauer R.M., Iwamoto G.A. Microinjection of GABA antagonists into the posterior hypothalamus elicits locomotor activity and a cardiorespiratory activation. Brain Res. 444:1988;84-94
62. Woolf C.J. The dorsal horn: state-dependent sensory processing and the generation of pain. Wall P.D., Melzack R. Textbook of pain. 1994;Churchill Livingstone, Edinburgh
63. Yamamoto T., Nozaki-Taguchi N., Chiba T. Analgesic effect of intrathecally administered orexin-A in the rat formalin test and in the rat hot plate test. Br J Pharmacol. 137:2002;170-176
64. Yamamoto T., Saito O., Shono K., Aoe T., Chiba T. Anti-mechanical allodynic effect of intrathecal and intracerebroventricular injection of orexin-A in the rat neuropathic pain model. Neurosci Lett. 347:2003;183-186
65. Zurak N. Role of the suprachiasmatic nucleus in the pathogenesis of migraine attacks. Cephalalgia. 17:1997;723-728